Conjunctival Lymphoma--An International Multicenter Retrospective Study

JAMA Ophthalmology
Marina M KirkegaardSteffen Heegaard

Abstract

To date, the clinical features of the various subtypes of conjunctival lymphoma (CL) have not been previously evaluated in a large cohort. To characterize subtype-specific clinical features of CL and their effect on patient outcome. A retrospective multicenter study was performed. Patient data were collected from January 1, 1980, through December 31, 2010. The dates of the analysis were May 15, 2015, to August 20, 2015. The median follow-up period was 43 months. Seven eye cancer centers were involved in the study. In total, 268 patients with CL were identified, 5 of whom were excluded because of missing clinical data. Overall survival, disease-specific survival, and progression-free survival were the primary end points. Two hundred sixty-three patients with CL were included in the study. Their mean age was 61.3 years, and 55.1% (145 of 263) were female. All lymphomas were of B-cell type. The most frequent subtype was extranodal marginal zone lymphoma (EMZL) (68.4% [180 of 263]), followed by follicular lymphoma (FL) (16.3% [43 of 263]), mantle cell lymphoma (MCL) (6.8% [18 of 263]), and diffuse large B-cell lymphoma (DLBCL) (4.6% [12 of 263). Conjunctival lymphoma commonly manifested in elderly individuals (age range, 60-70 year...Continue Reading

Citations

Jun 18, 2017·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Ga-In LeeYong Chan Ahn
Aug 18, 2017·The British Journal of Ophthalmology·Seung Wan NamYoon-Duck Kim
Sep 25, 2017·Clinical and Experimental Medicine·Dimitrios KalogeropoulosChris Kalogeropoulos
May 14, 2018·European Journal of Haematology·Marc SorigueJuan-Manuel Sancho
Dec 28, 2018·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Loren W Bennett
Aug 17, 2019·Current Molecular Medicine·Sacha Nahon-EstevePaul Hofman
Sep 9, 2017·International Ophthalmology Clinics·Rohini RaoJames Chodosh
Jun 10, 2019·The British Journal of Ophthalmology·Tine Gadegaard HindsøSteffen Heegaard
Aug 11, 2020·Klinische Monatsblätter für Augenheilkunde·Henrike WestekemperNikolaos Bechrakis
Sep 26, 2019·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·Claudia Auw-Hädrich, Thomas Reinhard
Jul 13, 2019·BMJ Case Reports·Jenny Jing LiNavid Sadeghi
Sep 12, 2018·Cancer Metastasis Reviews·Abhilasha Maheshwari, Paul T Finger
Feb 20, 2019·Virchows Archiv : an International Journal of Pathology·José CabeçadasAlfio Ferlito
Sep 11, 2020·Cancers·Gustavo SavinoAdriana Iuliano
Jul 29, 2017·BMC Ophthalmology·Sherine Jue OngHsin-Chiung Lin
Jul 1, 2020·BMJ Open Ophthalmology·Giannis A MoustafaDemetrios G Vavvas
Jun 8, 2017·International Ophthalmology Clinics·Afshan A NanjiCarol L Karp
Apr 12, 2017·Asia-Pacific Journal of Ophthalmology·Carol L ShieldsJerry A Shields
Aug 3, 2019·Eye and Vision·Rebecca E TanenbaumCarol L Karp
Jun 6, 2020·Ophthalmic Plastic and Reconstructive Surgery·William YoungRonald Mancini
May 1, 2021·The Medical Clinics of North America·Basil K Williams, Maura Di Nicola
Jul 29, 2021·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·André M TrouvainAnnekatrin Rickmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.